Nastoupil LJ, Jain MD, Feng L, Spiegel JY, et al. Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell
Lymphoma: Results From the US Lymphoma CAR T Consortium. J Clin Oncol 2020 May 13:JCO1902104. doi: 10.1200/JCO.19.02104.
PMID: 32401634